Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.

Hung-Jen ChenChih-Yen TuKuo-Yang HuangChun-Ru ChienTe-Chun Hsia

Published in: PloS one (2020)

Type of 4-TMpc 14 days after TKI targeted therapy is associated with an image response and PFS, without regarding mutation status, in patients with advanced lung adenocarcinoma.

Keyphrases

deep learning
tyrosine kinase
advanced non small cell lung cancer
metabolic syndrome
epidermal growth factor receptor
adipose tissue